Clinical Trials Search | Loyola Medicine

Study Title

A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma

Study Contact

Erin Rogers - Role: CONTACT - Phone: 210-614-8808 - Email: erogers@swog.org
Dana Sparks - Role: CONTACT - Phone: 210-614-8808 - Email: dsparks@swog.org

NCTID

NCT05633615

Recruitment Status

RECRUITING

Study Title

Pragmatica-Lung: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) Plus Pembrolizumab (MK-3475; NSC 776864) Versus Standard of Care for Participants Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer

Study Contact

NCTID

NCT05633602

Recruitment Status

RECRUITING

Study Title

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Study Contact

Akhilesh Sista - Role: CONTACT - Phone: 212-263-5898 - Email: aks9010@med.cornell.edu
Sunil Rao - Role: CONTACT - Phone: 212-263-0456 - Email: Sunil.rao@nyulangone.org

NCTID

NCT05591118

Recruitment Status

RECRUITING

Study Title

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance

Study Contact

Sharon Palmer - Role: CONTACT - Phone: 210-614-8808 - Email: spalmer@swog.org
Dana Sparks - Role: CONTACT - Phone: 210-614-8808 - Email: dsparks@swog.org

NCTID

NCT05561387

Recruitment Status

RECRUITING

Study Title

Urinary Microbiome Changes Following Administration of 500 Mg of NDS-446 in Women with Dry OAB At 12 Weeks - a Single-center Study

Study Contact

Mary Tulke, RN - Role: CONTACT - Phone: 708-216-2186 - Email: mtulke@luc.edu
Elizabeth Mueller, MD - Role: CONTACT - Phone: 708-216-2170 - Email: emuelle@lumc.edu

NCTID

NCT05557279

Recruitment Status

RECRUITING

Study Title

Phase II, Non-randomized, Open-label Study to Assess the Immunogenicity and Clinical Efficacy of the Recombinant Zoster Vaccine for Recipients of an Allogeneic Hematopoietic Stem Cell Transplant

Study Contact

Patrick A Hagen - Role: CONTACT - Phone: 708-327-3810 - Email: patrick.hagen@lumc.edu
Mary Lee - Role: CONTACT - Phone: 708-327-2241 - Email:

NCTID

NCT05554068

Recruitment Status

RECRUITING

Study Title

Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Catch in the Detection of Asymptomatic Bacteriuria in an Obstetric Population

Study Contact

Ann K Lal, MD - Role: CONTACT - Phone: 708-216-5439 - Email: ann.lal@lumc.edu
Namisha Dhillon, MD - Role: CONTACT - Phone: 708-216-5459 - Email: namisha.k.dhillon@luhs.org

NCTID

NCT05554081

Recruitment Status

ACTIVE_NOT_RECRUITING

Study Title

A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)

Study Contact

Max Kates, MD - Role: CONTACT - Phone: 4106140009 - Email: mkates@jhmi.edu

NCTID

NCT05538663

Recruitment Status

RECRUITING

Study Title

OrganOx Metra® New Enrollment Post-Approval Study

Study Contact

NCTID

NCT05526326

Recruitment Status

COMPLETED

Study Title

A Phase 2, Randomized, Double-blind, Placebo-controlled, 24-Week Study to Evaluate the Efficacy, Safety, and Tolerability of BBT-877, as Mono- or add-on Therapy, in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Study Contact

Bridge Biotherapeutics, Inc. - Role: CONTACT - Phone: +82-31-8092-3280 - Email: clinicaltrials.gov_inquiries@Bridgebiorx.com

NCTID

NCT05483907

Recruitment Status

COMPLETED